3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Breast Neoplasms
2
Neoplasm Metastasis
1
Liver Neoplasms
1
Colon Cancer Liver Metastasis
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Hepatocellular
1
Interventions
Gemcitabine
8
130-nm albumin-bound paclitaxel
5
Albumin-Bound Paclitaxel
4
napabucasin
2
Oxaliplatin
2
MK-4721
2
Leucovorin
2
Fluorouracil
2
Carboplatin
2
tremelimumab
1
irinotecan sucrosofate
1
ensituximab
1
durvalumab
1
contrast agent BR1
1
cc-486
1
Taxes
1
Practice Guidelines as Topic
1
Pancreaticoduodenectomy
1
Paclitaxel
1
PEGPH20
1
Lead
1
Irinotecan
1
Enoxaparin
1
EC regimen
1
Drug Therapy
1
Dexamethasone
1
Cisplatin
1
CP protocol
1
Azacitidine
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Pancreatic Ductal
×
contrast agent BR1
×
Clear all
NCT04146441
2023-01-19
PDAC
St. Olavs Hospital
Phase 2
Completed
20 enrolled